ORIGINAL RESEARCH

Changes in amino acid profile of cord blood plasma and amniotic fluid of mothers with COVID-19

About authors

Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia

Correspondence should be addressed: Natalia A. Lomova
Oparina, 4, Moscow, 117997; ur.xednay@avomol-ahsatan

About paper

Funding: the study was supported by RFBR grant №. 20-04-60093.

Author contribution: Lomova NA — analysis of clinical data, systematic analysis, manuscript writing; Chagovets VV — mass spectrometry-based metabolome analysis, statistical analysis of the results, manuscript editing; Dolgopolova EL — collection and preparation of biological matrix samples in the red zone, statistical analysis of the results; Novoselova AV — mass spectrometry-based metabolome analysis, mass spectrometry data processing; Petrova UL — collection and preparation of biological matrix samples in the red zone; Shmakov RG — analysis of clinical data in the red zone, systematic analysis, manuscript editing; Frankevich VE — preparation of the study, systematic analysis, manuscript writing and editing.

Compliance with ethical standards: the study was approved by the Ethics Committee of the National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V. I. Kulakov (protocol № 13 dated December 10, 2020); the study met the requirements of the Declaration of Helsinki, International Conference on Harmonization (ICF), Good Clinical Practice (GCP), and Federal Law № 323-FZ “On the Basics of Protecting Citizens' Health in the Russian Federation” of November 21, 2011; the informed consent was submitted by all patients.

Received: 2021-05-24 Accepted: 2021-06-18 Published online: 2021-06-29
|
Fig. 1. Amino acid concentrations in amniotic fluid of controls and COVID-19 patients. The first and the third quartiles form the boundaries of the box, the median is shown as a line in the center of the box; the ends of whiskers represent the following: one and a half times interquartile range subtracted from the first quartile, sum of the third quartile and one and a half times interquartile range; * — р ≤ 0.05; ** — р ≤ 0.01; *** — р ≤ 0.001; 1-mHis — 1-methylhistidine; 3-mHis — 3-methylhistidine; BAIBA — 3-aminoisobutyric acid; 5-OH-Lys — 5-hydroxylysine; MEA — ethanolamine; ABA — 2-aminobutyric acid; AAD — 2-aminoadipic acid; Car — carnosine; Cit — citrulline; Cyt — cystathionine; 4-OH-Pro — 4-hydroxyproline
Fig. 2. ROC curves for logistic regression models constructed for classification of controls and COVID-19 patients based on amino acid concentrations in amniotic fluid
Fig. 3. Amino acid concentrations in cord blood plasma of controls and COVID-19 patients. The first and the third quartiles form the boundaries of the box, the median is shown as a line in the center of the box; the ends of whiskers represent the following: one and a half times interquartile range subtracted from the first quartile, sum of the third quartile and one and a half times interquartile range; * — р ≤ 0.05; ** — р ≤ 0.01; *** — р ≤ 0.001. 1-mHis — 1-methylhistidine; 3-mHis – 3-methylhistidine; bAla — beta-alanine; BAIBA — 3-aminoisobutyric acid; 5-OH-Lys – 5-hydroxylysine; MEA – ethanolamine; ABA — 2-aminobutyric acid; AAD —2-aminoadipic acid; Car — carnosine; Cit — citrulline; Cyt — cystathionine; 4-OH-Pro — 4-hydroxyproline
Fig. 4. ROC curves for logistic regression models constructed for classification of controls and COVID-19 patients based on amino acid concentrations in cord blood plasma
Table 1. Clinical characteristics of pregnant women with COVID-19
Table 2. Clinical characteristics of pregnant women enrolled
Table 3. Amino acid concentrations (nmol/mL) in amniotic fluid of controls and COVID-19 patients
Table 4. Parameters of logistic regression models allowing one to distinguish patients with COVID-19 from patients with no COVID-19 based on the amino acid concentrations in the amniotic fluid
Table 5. Characteristics of logistic regression models allowing one to distinguish patients with COVID-19 from patients with no COVID-19 based on the amino acid concentrations in the amniotic fluid
Table 6. Amino acid concentrations (nmol/mL) in cord blood plasma of controls and COVID-19 patients
Table 7. Parameters of logistic regression models allowing one to distinguish patients with COVID-19 from patients with no COVID-19 based on the amino acid concentrations in the cord blood plasma
Table 8. Characteristics of logistic regression models allowing one to distinguish patients with COVID-19 from patients with no COVID-19 based on the amino acid concentrations in the blood cord plasma
Table 9. Amino acid concentrations (nmol/mL) in amniotic fluid and cord blood plasma showing significant differences between controls and COVID-19 patients